Электронная библиотека Финансового университета

     
?

Детальная информация
Карточка Таблица RUSMARC

PHARMACEUTICAL SCIENCES: breakthroughs in research and practice. — HERSHEY: MEDICAL INFOR Science IGI, 2017. — 1 online resource — <URL:http://elib.fa.ru/ebsco/1447283.pdf>.

Дата создания записи: 06.01.2017

Тематика: Drug development.; Pharmaceutical industry.; BUSINESS & ECONOMICS / Industries / General

Коллекции: EBSCO

Разрешенные действия: –

Действие 'Прочитать' будет доступно, если вы выполните вход в систему или будете работать с сайтом на компьютере в другой сети Действие 'Загрузить' будет доступно, если вы выполните вход в систему или будете работать с сайтом на компьютере в другой сети

Группа: Анонимные пользователи

Сеть: Интернет

Права на использование объекта хранения

Место доступа Группа пользователей Действие
Локальная сеть Финуниверситета Все Прочитать Печать Загрузить
Интернет Читатели Прочитать Печать
-> Интернет Анонимные пользователи

Оглавление

  • Title Page
  • Copyright Page
  • List of Contributors
  • Table of Contents
  • Preface
  • Section 1: Clinical Trials, Education, and Information Access
    • Chapter 1: Overview of Clinical Trial and Pharmacovigilance Process and Areas of Application of Computer System
    • Chapter 2: Pharmacogenomics Genome Wise Association Clinical Studies
    • Chapter 3: Normalizing Cross-Border Healthcare in Europe via New E-Prescription Paradigms
    • Chapter 4: Web 2.0 Tools in Biomedical and Pharmaceutical Education
    • Chapter 5: Open Access Initiatives in Medical Biology
  • Section 2: Drug Delivery and Patient Care
    • Chapter 6: Application of Nanoparticles as a Drug Delivery System
    • Chapter 7: Non-Ionic Surfactant Vesicles (Niosomes) as New Drug Delivery Systems
    • Chapter 8: Cancer Drug Delivery
    • Chapter 9: CNS Targeted Nanoparticle Drug Delivery
    • Chapter 10: Engineered Gellan Polysaccharides in the Design of Controlled Drug Delivery Systems
    • Chapter 11: Improving Pharmaceutical Care through the Use of Intelligent Pharmacoinformatics
    • Chapter 12: Personalized Medicine in the Era of Genomics
    • Chapter 13: Role of Resveratrol (RES) in Regenerative Medicine
    • Chapter 14: Strategies for Expanding Access and Improving the Quality of Pharmaceutical Services
    • Chapter 15: An Overview of Therapeutic Applications
    • Chapter 16: Bioinformatics and Its Therapeutic Applications
    • Chapter 17: A Perspective on the Phytopharmaceuticals Responsible for the Therapeutic Applications
    • Chapter 18: Resealed Erythrocytes as Drug Carriers and Its Therapeutic Applications
    • Chapter 19: Sedation and Analgesia
  • Section 3: Functional Foods
    • Chapter 20: Phytonutrients of Nutraceutical Importance
    • Chapter 21: Prediction of Structural and Functional Aspects of Protein
    • Chapter 22: Flavonoids
    • Chapter 23: Food Allergy and Food Poisoning
    • Chapter 24: Food and Cardiac Health
  • Section 4: Molecular Modeling and Drug Design
    • Chapter 25: Molecular-Docking-Based Drug Design and Discovery
    • Chapter 26: Role of Molecular Docking in Computer-Aided Drug Design and Development
    • Chapter 27: Molecular-Docking-Based Anti-Allergic Drug Design
    • Chapter 28: Molecular Docking Technique to Understand Enzyme-Ligand Interactions
    • Chapter 29: Molecular Modelling, Dynamics, and Docking of Membrane Proteins
    • Chapter 30: Molecular Docking Challenges and Limitations
    • Chapter 31: Different Types of Molecular Docking Based on Variations of Interacting Molecules
    • Chapter 32: The Comparison of Docking Search Algorithms and Scoring Functions
    • Chapter 33: Application of Docking Methodologies in QSAR-Based Studies
    • Chapter 34: Protein Structure Prediction Using Homology Modeling
    • Chapter 35: QSAR Studies on Bacterial Efflux Pump Inhibitors
    • Chapter 36: QSPR/QSAR Analyses by Means of the CORAL Software
    • Chapter 37: 2D and 3D QSAR Studies on a Series of Antichagasic Fenarimol Derivatives
    • Chapter 38: The “ETA” Indices in QSAR/QSPR/QSTR Research
    • Chapter 39: Importance of Applicability Domain of QSAR Models
    • Chapter 40: Molecular Dynamics Simulations for Biological Systems
    • Chapter 41: Protein Ligand Interaction Fingerprints
    • Chapter 42: Protein-Protein Docking
    • Chapter 43: Protein-Protein Interactions (PPIs) as an Alternative to Targeting the ATP Binding Site of Kinase
    • Chapter 44: Rational Drug Design Rational Drug Design
    • Chapter 45: Smart, Innovative and Intelligent Technologies Used in Drug Designing
  • Section 5: Nanostructures and Technology
    • Chapter 46: Hybrid Plasmonic Nanostructures
    • Chapter 47: Implementation of Nanoparticles in Cancer Therapy
    • Chapter 48: Nanomedicine
    • Chapter 49: Nanosuspensions in Nanobiomedicine
    • Chapter 50: Quantitative Nanostructure-Activity Relationship Models for the Risk Assessment of NanoMaterials
    • Chapter 51: QSAR-Based Studies of Nanomaterials in the Environment
    • Chapter 52: Stratagems of Nanotechnology Augmenting the Bioavailability and Therapeutic Efficacy of Traditional Medicine to Formulate Smart Herbal Drugs Combating
  • Section 6: Toxicology
    • Chapter 53: Toxic Effects of Engineered Nanoparticles on Living Cells
    • Chapter 54: Cyanobacterial Toxins in Water Sources and Their Impacts on Human Health
    • Chapter 55: Pharmaceuticals and Personal Care Products as Emerging Water Contaminants
    • Chapter 56: Toxicological Effects of Carbon Nanotubes
    • Chapter 57: Understanding Toxicity of Nanomaterials in Biological Systems
    • Chapter 58: Quantitative Structure-Activity/Property/Toxicity Relationships through Conceptual Density Functional Theory-Based Reactivity Descriptors
    • Chapter 59: Quasi-SMILES for Nano-QSAR Prediction of Toxic Effect of Al2O3 Nanoparticles
  • Index

Статистика использования

stat Количество обращений: 0
За последние 30 дней: 0
Подробная статистика